EGFR is overexpressed in a substantial proportion of NPC tumors and contributes to proliferation, metastasis, and treatment resistance via the activation of the PI3K/AKT and MAPK signaling pathways [82]. Here, EGFR is linked to nasopharyngeal carcinoma.